Funding Opportunities (19/12/2018)

Spring 2019 Project Grant Competition (CIHR, Canada)

The Canadian Institutes for Health Research has launched its spring funding opportunity. This announcement is desinged to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, healthcare, health systems, and/or health outcomes. It supports projects with a specific pupose and a defined endpoint.

DEADLINE: February 6, 2019 for the letter of intent and March 6, 2019 for the application. More information can be  found here.

Clinical and Translational Science Award

On September 27, 2018, NIH announced new funding opportunity. The project period is limited to five years starting from December 25, 2018. The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in the Clinical and Translational Science Award (CTSA) Program which supports high quality translational science and clinical research locally, regionally and nationally and fosters innovation in research methods, training, and career development. More information can be found here.

1st JOINT CALL FOR EUROPEAN JOINT PROGRAMME ON RARE DISEASES (JTC 2019)

The pre-announcement of the Joint Transnational Call 2019 of EJP RD Pillar 1 has been published. The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear benefit for patients.

The topic: Research projects to accelerate diagnosis and/or explore disease progression and mechanisms of rare diseases.

There will be a two-stage submission procedure for joint applications: pre-proposals and full proposals. The call is scheduled to open on December 14, 2018. The indicative deadline for submitting the pre-proposals is foreseen for February 14, 2019. An independent international Scientific Evaluation Committee will carry out a scientific evaluation according to specific evaluation criteria. Based on this central evaluation, selected consortia will be invited to submit a full proposal by early May 2019 (indicative deadline for full proposals: June 11, 2019).

After the completion of ERA-Net E-Rare Joint Transnational Calls for rare disease research projects this effort is now continued in the frame of the European Joint Programme on Rare Diseases (EJP RD). The European Joint Programme on Rare Diseases (EJP-RD) was accepted in August by the European Commission. It will run from January 2019 to December 2024, consists of 85 partners (including the 24 European Reference Networks, Eurordis and Inserm/Orphanet) from 33 participating countries, and has a total budget of over 90 Million Euros. This programme aims to develop an efficient model of financial support for all types of rare disease research by the creation of a research and innovation pipeline in order to ensure a rapid translation of research results into clinical applications and uptake in healthcare, for the benefit of all patients. Please find more information here.

Funding Opportunities (3/10/2018)

New Funding Opportunities Available for Collaborative Rare Diseases Research

On June 11, 2018, NCATS announced two new Rare Diseases Clinical Research Network (RDCRN) program funding opportunities to support collaborative clinical research on rare diseases. The Center is accepting applications for Rare Diseases Clinical Research Consortia and a Data Management and Coordinating Center (DMCC); both funding opportunities have a deadline of Oct. 9, 2018. More information can be found here.

Clinical and Translational Science Award (U54 Clinical Trial Optional)

On September 27, 2018, NIH announced new funding opportunity. The project period is limited to five years starting from December 25, 2018. The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in the Clinical and Translational Science Award (CTSA) Program which supports high quality translational science and clinical research locally, regionally and nationally and fosters innovation in research methods, training, and career development. More information can be found here.